Hyaluronic acid levels predict increased risk of non-AIDS death in hepatitis-coinfected persons interrupting antiretroviral therapy in the SMART Study

Research output: Contribution to journal › Journal article › Research › peer-review

  • Lars Peters
  • Jacqueline Neuhaus
  • Amanda Mocroft
  • Vincent Soriano
  • Jürgen Rockstroh
  • Gregory Dore
  • Massimo Puoti
  • Ellen Tedaldi
  • Bonaventura Clotet
  • Bernd Kupfer
  • Lundgren, Jens
  • Marina B Klein
  • SMART Study Group
In the SMART study, HIV-viral-hepatitis-coinfected persons were, compared with HIV-monoinfected persons, at higher risk of non-AIDS death if randomized to the antiretroviral therapy (ART) interruption strategy. We hypothesized that a marker of liver fibrosis, hyaluronic acid (HA), would be predictive of development of non-AIDS-related outcomes in coinfected participants in the SMART study.
Original languageEnglish
JournalAntiviral Therapy
Volume16
Issue number5
Pages (from-to)667-75
Number of pages9
ISSN1359-6535
DOIs
Publication statusPublished - 1 Jan 2011

ID: 35412232